Article

neworleanscitybusiness.com on 2015-08-27 18:16

FDA lays out naming rules for lower-cost biotech drugs

Europe

Related news

CFDA lays out naming rules for lower-cost biotech drugs contracostatimes.com
Europe
CFDA lays out proposal for naming lower-cost biotech drugs contracostatimes.com
Europe
FDA lays out proposal for naming generic biotech drugs observer-reporter.com
Europe
FDA approves first lower-cost biotech drug observer-reporter.com
Switzerland , Europe
FDA approves lower-cost alternative to biotech drug Humira seattletimes.com
Illinois , North Chicago , Thousand Oaks , Wall Street , Europe
FDA panel endorses first lower-cost biotech drug seattletimes.com
Switzerland , Sanford , Europe , United States
Lower-cost biotech drug gets thumbs up from FDA panel reviewtimes.com
Ohio , Hancock
Justices Hear Dispute Over Lower-Cost Biotech Drugs Sales memphisdailynews.com
Switzerland
Justices hear dispute over lower-cost biotech drugs sales KHQ Local News
Spokane
FFDA paves way for biosimilar drugs ft.com
Europe , Americas , New York
First biosimilar drug approved by FDA, cheaper biotech medication on way San Jose Mercury News
Switzerland , Europe
FDA Releases Naming Guidance jdsupra.com
New life for failed drugs? A biotech veteran’s new startup sees a path to FDA approval.bizjournals.com
Maryland